Mira Pharmaceuticals Inc (MIRA)
0.8182
+0.02
(+2.28%)
USD |
NASDAQ |
May 31, 16:00
0.879
+0.06
(+7.43%)
After-Hours: 20:00
Mira Pharmaceuticals Price to Book Value: 3.831 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 3.831 |
| May 30, 2024 | 3.746 |
| May 29, 2024 | 4.115 |
| May 28, 2024 | 3.980 |
| May 24, 2024 | 4.144 |
| May 23, 2024 | 4.120 |
| May 22, 2024 | 4.287 |
| May 21, 2024 | 4.776 |
| May 20, 2024 | 3.980 |
| May 17, 2024 | 3.067 |
| May 16, 2024 | 3.182 |
| May 15, 2024 | 3.298 |
| May 14, 2024 | 3.457 |
| May 13, 2024 | 3.358 |
| May 10, 2024 | 3.371 |
| May 09, 2024 | 3.512 |
| May 08, 2024 | 3.558 |
| May 07, 2024 | 3.558 |
| May 06, 2024 | 3.512 |
| May 03, 2024 | 3.432 |
| May 02, 2024 | 3.783 |
| May 01, 2024 | 3.836 |
| April 30, 2024 | 3.980 |
| April 29, 2024 | 3.980 |
| April 26, 2024 | 4.026 |
| Date | Value |
|---|---|
| April 25, 2024 | 4.214 |
| April 24, 2024 | 4.074 |
| April 23, 2024 | 4.112 |
| April 22, 2024 | 4.003 |
| April 19, 2024 | 3.894 |
| April 18, 2024 | 3.924 |
| April 17, 2024 | 3.792 |
| April 16, 2024 | 3.699 |
| April 15, 2024 | 3.886 |
| April 12, 2024 | 4.216 |
| April 11, 2024 | 4.589 |
| April 10, 2024 | 4.678 |
| April 09, 2024 | 4.683 |
| April 08, 2024 | 4.823 |
| April 05, 2024 | 4.776 |
| April 04, 2024 | 4.776 |
| April 03, 2024 | 5.01 |
| April 02, 2024 | 5.01 |
| April 01, 2024 | 5.057 |
| March 28, 2024 | 3.717 |
| March 27, 2024 | 3.683 |
| March 26, 2024 | 3.886 |
| March 25, 2024 | 3.920 |
| March 22, 2024 | 4.156 |
| March 21, 2024 | 4.258 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.894
Minimum
Dec 20 2023
91.43
Maximum
Aug 03 2023
17.13
Average
4.003
Median
Apr 22 2024
Price to Book Value Benchmarks
| Merck & Co Inc | 7.878 |
| Altimmune Inc | 3.079 |
| 180 Life Sciences Corp | -- |
| Innovative Eyewear Inc | 3.791 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 0.8182 |
| Earnings Yield | -104.8% |
| Market Cap | 12.09M |